$POLA
Polar Power, Inc.

2023 Q4 Form 10-Q Financial Statement

#000149315223041120 Filed on November 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q4 2023 Q3
Revenue $3.605M $1.911M
YoY Change -43.37% 11.95%
Cost Of Revenue $5.032M $2.019M
YoY Change -15.57% 3.33%
Gross Profit -$1.427M -$108.0K
YoY Change -451.48% -56.28%
Gross Profit Margin -39.58% -5.65%
Selling, General & Admin $1.488M $1.266M
YoY Change 1.57% -30.06%
% of Gross Profit
Research & Development $239.0K $299.0K
YoY Change -24.13% -6.27%
% of Gross Profit
Depreciation & Amortization $77.00K $82.00K
YoY Change -35.83% -33.87%
% of Gross Profit
Operating Expenses $1.545M $1.565M
YoY Change -10.75% -26.49%
Operating Profit -$2.972M -$1.673M
YoY Change 124.3% -29.59%
Interest Expense -$184.0K $171.0K
YoY Change 868.42% 1325.0%
% of Operating Profit
Other Income/Expense, Net $1.000K -$171.0K
YoY Change 3320.0%
Pretax Income -$3.155M -$1.840M
YoY Change 134.75% -22.72%
Income Tax
% Of Pretax Income
Net Earnings -$3.155M -$1.844M
YoY Change 134.75% -22.55%
Net Earnings / Revenue -87.52% -96.49%
Basic Earnings Per Share -$0.14
Diluted Earnings Per Share -$0.22 -$0.14
COMMON SHARES
Basic Shares Outstanding 12.96M shares 12.95M shares
Diluted Shares Outstanding 12.95M shares

Balance Sheet

Concept 2023 Q4 2023 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $549.0K $300.0K
YoY Change 160.19% -17.36%
Cash & Equivalents $549.0K $296.0K
Short-Term Investments
Other Short-Term Assets $2.455M $2.940M
YoY Change -46.96% -53.54%
Inventory $16.52M $19.16M
Prepaid Expenses $455.0K $942.0K
Receivables $1.676M $1.582M
Other Receivables $787.0K $790.0K
Total Short-Term Assets $21.99M $24.76M
YoY Change -5.7% 1.82%
LONG-TERM ASSETS
Property, Plant & Equipment $3.162M $423.0K
YoY Change 487.73% -35.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $108.0K $110.0K
YoY Change 16.13% 18.28%
Total Long-Term Assets $3.270M $3.634M
YoY Change 275.43% 213.01%
TOTAL ASSETS
Total Short-Term Assets $21.99M $24.76M
Total Long-Term Assets $3.270M $3.634M
Total Assets $25.26M $28.40M
YoY Change 4.43% 11.44%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.762M $1.988M
YoY Change 666.09% 367.76%
Accrued Expenses $2.275M $2.220M
YoY Change 51.77% 36.03%
Deferred Revenue
YoY Change
Short-Term Debt $4.238M $5.190M
YoY Change 124.95%
Long-Term Debt Due $321.0K $320.0K
YoY Change 52.13% 29.03%
Total Short-Term Liabilities $10.21M $11.45M
YoY Change 71.66% 94.86%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $1.856M $2.160M
YoY Change
Total Long-Term Liabilities $1.856M $2.160M
YoY Change 3156.14% 2566.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.21M $11.45M
Total Long-Term Liabilities $1.856M $2.160M
Total Liabilities $12.07M $13.61M
YoY Change 100.93% 128.51%
SHAREHOLDERS EQUITY
Retained Earnings -$25.66M -$22.50M
YoY Change 34.26% 26.66%
Common Stock $2.000K $1.000K
YoY Change 100.0% 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $13.19M $14.79M
YoY Change
Total Liabilities & Shareholders Equity $25.26M $28.40M
YoY Change 4.43% 11.44%

Cashflow Statement

Concept 2023 Q4 2023 Q3
OPERATING ACTIVITIES
Net Income -$3.155M -$1.844M
YoY Change 134.75% -22.55%
Depreciation, Depletion And Amortization $77.00K $82.00K
YoY Change -35.83% -33.87%
Cash From Operating Activities -$350.0K -$280.0K
YoY Change -82.28% -87.39%
INVESTING ACTIVITIES
Capital Expenditures $4.000K $0.00
YoY Change -100.0%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.000K $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 602.0K 280.0K
YoY Change -66.98% -551.61%
NET CHANGE
Cash From Operating Activities -350.0K -280.0K
Cash From Investing Activities -4.000K 0.000
Cash From Financing Activities 602.0K 280.0K
Net Change In Cash 248.0K -0.0000000003492
YoY Change -263.16% -100.0%
FREE CASH FLOW
Cash From Operating Activities -$350.0K -$280.0K
Capital Expenditures $4.000K $0.00
Free Cash Flow -$354.0K -$280.0K
YoY Change -82.08% -87.34%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Amendment Flag
AmendmentFlag
false
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Central Index Key
EntityCentralIndexKey
0001622345
CY2023Q3 us-gaap Long Term Notes Payable
LongTermNotesPayable
usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
usd
us-gaap Share Based Compensation
ShareBasedCompensation
usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
usd
POLA Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted
shares
POLA Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised
shares
POLA Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-37960
dei Entity Registrant Name
EntityRegistrantName
POLAR POWER, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
33-0479020
dei Entity Address Address Line1
EntityAddressAddressLine1
249 E. Gardena Blvd.
dei Entity Address City Or Town
EntityAddressCityOrTown
Gardena
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
90248
dei City Area Code
CityAreaCode
(310)
dei Local Phone Number
LocalPhoneNumber
830-9153
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
dei Security12b Title
Security12bTitle
Common Stock, par value $0.0001 per share
dei Trading Symbol
TradingSymbol
POLA
dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2023Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
12961612 shares
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
296000 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
211000 usd
CY2023Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
1582000 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
2230000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
19155000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
15460000 usd
CY2023Q3 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
942000 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
2629000 usd
CY2023Q3 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2022Q4 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2023Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
787000 usd
CY2022Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
787000 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
24762000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
23317000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3103000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
240000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
423000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
538000 usd
CY2023Q3 us-gaap Deposit Assets
DepositAssets
108000 usd
CY2022Q4 us-gaap Deposit Assets
DepositAssets
93000 usd
CY2023Q3 us-gaap Assets
Assets
28396000 usd
CY2022Q4 us-gaap Assets
Assets
24188000 usd
CY2023Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1988000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
230000 usd
CY2023Q3 us-gaap Deposits
Deposits
1720000 usd
CY2022Q4 us-gaap Deposits
Deposits
2126000 usd
CY2023Q3 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1178000 usd
CY2022Q4 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
1231000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1045000 usd
CY2022Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
268000 usd
CY2023Q3 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
5194000 usd
CY2022Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
1884000 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
11446000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5950000 usd
CY2022Q4 us-gaap Long Term Notes Payable
LongTermNotesPayable
57000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2162000 usd
CY2023Q3 us-gaap Liabilities
Liabilities
13608000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
6007000 usd
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000 shares
CY2023Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12967027 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12949550 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12967027 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12949550 shares
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37331000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
37331000 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-22504000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-19111000 usd
CY2023Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
17477 shares
CY2022Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
17477 shares
CY2023Q3 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
40000 usd
CY2022Q4 us-gaap Treasury Stock Common Value
TreasuryStockCommonValue
40000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
14788000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18181000 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
28396000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24188000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1911000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1707000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11688000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9690000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2019000 usd
CY2022Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1954000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
9566000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
7971000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
-108000 usd
CY2022Q3 us-gaap Gross Profit
GrossProfit
-247000 usd
us-gaap Gross Profit
GrossProfit
2122000 usd
us-gaap Gross Profit
GrossProfit
1719000 usd
CY2023Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
274000 usd
CY2022Q3 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
328000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
917000 usd
us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1134000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
299000 usd
CY2022Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
319000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
983000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1145000 usd
CY2023Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
992000 usd
CY2022Q3 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1482000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3240000 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3648000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1565000 usd
CY2022Q3 us-gaap Operating Expenses
OperatingExpenses
2129000 usd
us-gaap Operating Expenses
OperatingExpenses
5140000 usd
us-gaap Operating Expenses
OperatingExpenses
5927000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1673000 usd
CY2022Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2376000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3018000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4208000 usd
CY2023Q3 us-gaap Interest Expense
InterestExpense
171000 usd
CY2022Q3 us-gaap Interest Expense
InterestExpense
12000 usd
us-gaap Interest Expense
InterestExpense
375000 usd
us-gaap Interest Expense
InterestExpense
39000 usd
CY2022Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
7000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-171000 usd
CY2022Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-5000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-375000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-32000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1844000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2381000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3393000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4240000 usd
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.14
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.14
CY2022Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.19
CY2022Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.19
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.26
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.26
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.33
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.33
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12949550 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12949550 shares
CY2022Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12848466 shares
CY2022Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12848466 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12949550 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12949550 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12967027 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12967027 shares
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
16632000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-1844000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
14788000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
18181000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3393000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
14788000 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
21391000 usd
CY2022Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
515000 usd
CY2022Q3 us-gaap Net Income Loss
NetIncomeLoss
-2381000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
19525000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
23250000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
515000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4240000 usd
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
19525000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3393000 usd
us-gaap Net Income Loss
NetIncomeLoss
-4240000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
309000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
387000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
515000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-648000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3027000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
3695000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6608000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1687000 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
322000 usd
us-gaap Increase Decrease In Deposit Other Assets
IncreaseDecreaseInDepositOtherAssets
15000 usd
POLA Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
2863000 usd
POLA Increase Decrease In Operating Lease Right Of Use Asset
IncreaseDecreaseInOperatingLeaseRightOfUseAsset
-503000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1758000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
97000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
-406000 usd
us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
2672000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-53000 usd
us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
-27000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
2939000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-536000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3084000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-4532000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
194000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-194000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-25000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
3310000 usd
POLA Proceeds From Notes Payable Related Party
ProceedsFromNotesPayableRelatedParty
-233000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
180000 usd
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
181000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3363000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-181000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
85000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-4738000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
211000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5101000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
296000 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
363000 usd
us-gaap Net Income Loss
NetIncomeLoss
-3393000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3084000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
296000 usd
CY2023Q3 us-gaap Line Of Credit
LineOfCredit
119000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
14788000 usd
CY2023Q3 POLA Working Capital
WorkingCapital
13316000 usd
us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
384000 usd
CY2022 us-gaap Standard Product Warranty Accrual Payments
StandardProductWarrantyAccrualPayments
508000 usd
POLA Standard Product Warranty Accrual Provision
StandardProductWarrantyAccrualProvision
384000 usd
CY2022 POLA Standard Product Warranty Accrual Provision
StandardProductWarrantyAccrualProvision
508000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2023Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
1300000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84B_eus-gaap--UseOfEstimates_zaejdZTZpBr" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zn1O0qPNqb32">Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Material estimates relate to the assumptions made in determining reserves for uncollectible receivables, inventory net realizable value, impairment analysis of long-term assets, valuation allowance on deferred tax assets, accruals for potential liabilities, accruals for warranty reserves, assumptions made in valuing equity instruments issued for services, and assumptions used in the determination of the Company’s liquidity. Actual results may differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1911000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1707000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11688000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9690000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1911000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1707000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11688000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9690000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1911000 usd
CY2022Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
1707000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
11688000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
9690000 usd
POLA Description Of Warrant Expiration Date
DescriptionOfWarrantExpirationDate
expire in July 2025
CY2023Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue
0 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
2596000 usd
CY2023Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
15580000 usd
CY2022Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
12277000 usd
CY2023Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3575000 usd
CY2022Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
3183000 usd
CY2023Q3 us-gaap Inventory Net
InventoryNet
19155000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
15460000 usd
CY2023Q3 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2022Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
CY2021Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
600000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_84F_eus-gaap--ConcentrationRiskCreditRisk_zWfVbDdcfC5a" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_861_zI1oBJj8raCa">Concentrations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Cash</i>. The Company maintains cash balances at four banks, with the majority held at one bank located in the U.S. At times, the amount on deposit exceeds the federally insured limits. Management believes that the financial institutions that hold the Company’s cash are financially sound and, accordingly, minimal credit risk exists.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cash denominated in Australian Dollars with a U.S. Dollar equivalent of $<span id="xdx_90C_eus-gaap--Cash_iI_pn3n3_c20230930__srt--CurrencyAxis__currency--AUD_zyQu6gnP7je5" title="Cash">14</span> and $<span id="xdx_90D_eus-gaap--Cash_iI_pn3n3_c20221231__srt--CurrencyAxis__currency--AUD_zAMo61pAYQC4" title="Cash">8</span> at September 30, 2023 and December 31, 2022, respectively, was held in an account at a financial institution located in Australia. Cash denominated in Romanian Leu with a U.S. Dollar equivalent of $<span id="xdx_907_eus-gaap--Cash_iI_pn3n3_c20230930__srt--CurrencyAxis__currency--RON_zDjrdrt9gaRc" title="Cash">1</span> and $<span id="xdx_901_eus-gaap--Cash_iI_pn3n3_c20221231__srt--CurrencyAxis__currency--RON_z9WJHYHvi3C" title="Cash">23</span> at September 30, 2023 and December 31, 2022, respectively, was held in an account at a financial institution located in Romania.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revenues. </i>For the three months ended September 30, 2023, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z4RcciPgTQjf" title="Concentration risk">65</span>% of revenues were generated from the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S. For the three months ended September 30, 2022, <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zGsZwE3staGa" title="Concentration risk">87</span>% of revenues were generated from the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S. There was no other revenue from customers in excess of 10% of revenues in either period. For the three months ended September 30, 2023 and September 30, 2022, sales to telecommunications customers accounted for <span id="xdx_905_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zAMdfUOzicpl" title="Concentration risk">96</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zO1f2jfYYxB8" title="Concentration risk">90</span>% of total revenues, respectively. For the three months ended September 30, 2023 and September 30, 2022, sales to international customers accounted for <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230701__20230930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zr6uDoPFCTCg" title="Concentration risk">1</span>% and <span id="xdx_904_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220701__20220930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zYaAq1aNtJr8" title="Concentration risk">7</span>%, of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the nine months ended September 30, 2023, sales to the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S., accounted for <span id="xdx_90B_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zjTuMR482edd" title="Concentration risk">52</span>% of total revenues, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zVAutpwY9g77" title="Concentration risk">22</span>% of revenue was generated from the Company’s second largest customer, a telecommunications customer outside the U.S. For the same period in 2022, sales to the Company’s largest customer, a Tier-1 telecommunications wireless carrier in the U.S., accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__srt--StatementGeographicalAxis__country--US__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zIVL1mMd7GGd" title="Concentration risk">88</span>%. There was no other revenue from customers in excess of 10% of revenues in either period. For the nine months ended September 30, 2023 and September 30, 2022, sales to telecommunications customers accounted for <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_znicWpYhh6z8" title="Concentration risk">96</span>% and <span id="xdx_90D_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_z3xWbZSLIlFa" title="Concentration risk">97</span>% of total revenues, respectively. For the nine months ended September 30, 2023 and September 30, 2022, sales to international customers accounted for <span id="xdx_90C_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zJ1sPZrOQfT2" title="Concentration risk">24</span>% and <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20220930__srt--ProductOrServiceAxis__custom--SalesToTelecommunicationsCustomersMember__srt--StatementGeographicalAxis__us-gaap--NonUsMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--RevenueFromContractWithCustomerMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--RevenueFromRightsConcentrationRiskMember_zCTgggPnZRS7" title="Concentration risk">2</span>%, of total revenue, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts receivable</i>. At September 30, 2023, the two largest accounts receivable from the Company’s customers represented <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zhuPr6xnBMZj" title="Concentration risk">79</span>% and <span id="xdx_903_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zAYFs273AXD7" title="Concentration risk">10</span>%, of the Company’s total accounts receivable. At December 31, 2022, the Company’s two largest receivable accounts represented <span id="xdx_90E_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_zyCOLo6OKWMc" title="Concentration risk">74</span>% and <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestCustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember_z6xzYBfN9qJ9" title="Concentration risk">15</span>% of the Company’s total accounts receivable. There was no other customer that accounted for more than 10% of the Company’s accounts receivable as of September 30, 2023 or December 31, 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Accounts payable</i>. At September 30, 2023, accounts payable to the Company’s three largest vendors represented <span id="xdx_906_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--LargestVendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z4aswddDR9ka" title="Concentration risk">34</span>%, <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--LargestVendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zqRzTGVQcVF9" title="Concentration risk">13</span>% and <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20230930__srt--MajorCustomersAxis__custom--LargestVendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_ziAET4ju59Le" title="Concentration risk">6</span>%, of the Company’s accounts payable. On December 31, 2022, the three largest accounts payable accounts to the Company’s vendors represented <span id="xdx_909_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zX6KpM4NCZek" title="Concentration risk">51</span>%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_z9WRh218gyKa" title="Concentration risk">3</span>%, and <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20220101__20221231__srt--MajorCustomersAxis__custom--LargestVendorThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsPayableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--SupplierConcentrationRiskMember_zmLA4G1NjzG1" title="Concentration risk">3</span>%, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
164122 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
164122 shares
CY2023Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4494000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
4300000 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
4071000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3762000 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
423000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
538000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
82000 usd
CY2022Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
124000 usd
CY2023Q3 us-gaap Depreciation
Depreciation
79000 usd
CY2022Q3 us-gaap Depreciation
Depreciation
119000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
309000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
387000 usd
us-gaap Depreciation
Depreciation
298000 usd
us-gaap Depreciation
Depreciation
374000 usd
CY2023Q3 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
58000 usd
CY2023Q3 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
74000 usd
CY2023Q3 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
84000 usd
CY2023Q1 POLA Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities
InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities
2392000 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.22
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
5.22
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
140000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.22
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
140000 shares
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0 usd
CY2022Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
24122 shares
CY2022Q4 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2023Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber
24122 shares
CY2023Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice
3.13
CY2023Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2023Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableWeightedAverageExercisePrice
3.13
CY2023Q3 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2022Q4 POLA Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisableNumber
24122 shares
CY2023Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
3.13
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year
LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear
31000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
37000 usd
CY2023Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
41000 usd
CY2023Q2 POLA Initial Recognition Of Operating Lease Rightofuse Assets And Operating Lease Liabilities
InitialRecognitionOfOperatingLeaseRightofuseAssetsAndOperatingLeaseLiabilities
1184000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1013000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
726000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
1013000 usd
us-gaap Operating Lease Cost
OperatingLeaseCost
726000 usd
CY2023Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y8M12D
CY2022Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P0Y8M12D
CY2023Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0513 pure
CY2022Q3 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0375 pure
CY2023Q3 POLA Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
409000 usd
CY2022Q3 POLA Operating Lease Right Of Use Asset Accumulated Amortization
OperatingLeaseRightOfUseAssetAccumulatedAmortization
2406000 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
3103000 usd
CY2022Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
411000 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
1045000 usd
CY2022Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
453000 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
2162000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3207000 usd
CY2022Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
453000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
267000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1250000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1446000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
496000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
3459000 usd
CY2023Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
252000 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
3207000 usd
us-gaap Payments For Rent
PaymentsForRent
1023000 usd
us-gaap Payments For Rent
PaymentsForRent
726000 usd
CY2021 POLA Employee Retention Credits Wages Percentage
EmployeeRetentionCreditsWagesPercentage
0.70 pure
CY2021 POLA Employee Retention Credits Per Shares
EmployeeRetentionCreditsPerShares
7
CY2021Q4 POLA Expenses Of Employee Retention Credit
ExpensesOfEmployeeRetentionCredit
2000000 usd
CY2023Q3 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd
CY2022Q4 POLA Employee Retention Credit Receivable
EmployeeRetentionCreditReceivable
2000000 usd

Files In Submission

Name View Source Status
0001493152-23-041120-index-headers.html Edgar Link pending
0001493152-23-041120-index.html Edgar Link pending
0001493152-23-041120.txt Edgar Link pending
0001493152-23-041120-xbrl.zip Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
pola-20230930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
pola-20230930_cal.xml Edgar Link unprocessable
pola-20230930_lab.xml Edgar Link unprocessable
pola-20230930_def.xml Edgar Link unprocessable
pola-20230930_pre.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending